Fig. 3From: Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapyPooled estimates of the network meta-analysis. A Pooled hazard ratios (95% credible intervals) for progression-free survival(lower triangle) and overall survival(upper triangle). B Pooled odds ratios (95% credible intervals) for objective response rate(lower triangle) and rate of grade3-4 toxicity assessment(upper triangle)Back to article page